NEWS: $198.5M Partnership with Canada & Alberta Govts to Biomanufacture Next-Gen Meds

Entos Pharmaceuticals
Home
Technology
Pipeline & Partners
Team
News & Media
Careers & Culture
Contact
Entos Pharmaceuticals
Home
Technology
Pipeline & Partners
Team
News & Media
Careers & Culture
Contact
More
  • Home
  • Technology
  • Pipeline & Partners
  • Team
  • News & Media
  • Careers & Culture
  • Contact
  • Home
  • Technology
  • Pipeline & Partners
  • Team
  • News & Media
  • Careers & Culture
  • Contact

Roy Duncan, PhD

SCIENTIFIC FOUNDER

Dr. Roy Duncan, Professor and Killam Chair at Dalhousie University, is an internationally renowned expert on viral fusion proteins. His research group discovered the reovirus fusion-associated small transmembrane (FAST) proteins, a novel family of virus-encoded fusogens that mediate cell-cell membrane fusion. Dr. Duncan is also the founder and chief executive officer of Fusogenix Inc. Roy Duncan has published extensively on protein trafficking, unconventional secretion pathways, cancer cell migration, cell-cell fusion mechanisms, and FAST proteins. Dr. Duncan received his Ph.D. from Guelph University.

Copyright © 2025 Entos Pharmaceuticals - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept